Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean sars amino?
Displaying drugs 4451 - 4475 of 4632 in total
BMS-394136 has been used in trials studying the diagnostic of Heart Diseases.
Investigational
BMS-911543 has been used in trials studying the treatment of Cancer.
Investigational
Experimental
Investigational
VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis).
Investigational
Telatinib is under investigation in clinical trial NCT03817411 (Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer).
Investigational
N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide is a solid. This compound belongs to the n-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. It is known to target cathepsin K.
Experimental
Experimental
Methyl undecenoyl leucinate is an active ingredient in whitening creams. It is an α-MSH antagonist that inhibits melanin synthesis and tyrosinase activity and reduces expression of various melanogenic genes.
Experimental
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.
Investigational
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
Experimental
N-(3-carboxypropanoyl)-L-norvaline is a solid. This compound belongs to the n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom. This medication is known to target n-acetylornithine carbamoyltransferase and putative ornithine carbamoyltransferase.
Experimental
Experimental
Displaying drugs 4451 - 4475 of 4632 in total